1988 - 1991年在挪威中学进行的一项针对B群脑膜炎球菌病的外膜囊泡疫苗效力试验中，接种疫苗或安慰剂后的不良事件。 - Suppr | 超能文献

Adverse events following vaccine or placebo injection in an efficacy trial of an outer membrane vesicle vaccine against group B meningococcal disease in Norwegian secondary schools 1988-1991.

作者信息

Aavitsland P, Bjune G, Aasen S, Halvorsen S

机构信息

Department of Infectious Disease Control, National Institute of Publich Health, Oslo.

出版信息

NIPH Ann. 1991 Dec;14(2):133-4; discussion 136-7.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Adverse events following vaccine or placebo injection in an efficacy trial of an outer membrane vesicle vaccine against group B meningococcal disease in Norwegian secondary schools 1988-1991.1988 - 1991年在挪威中学进行的一项针对B群脑膜炎球菌病的外膜囊泡疫苗效力试验中，接种疫苗或安慰剂后的不良事件。

NIPH Ann. 1991 Dec;14(2):133-4; discussion 136-7.

2

Results of an efficacy trial with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway.挪威一项针对B群脑膜炎球菌病全身性疾病的外膜囊泡疫苗疗效试验的结果。

NIPH Ann. 1991 Dec;14(2):125-30; discussion 130-2.

3

The meningococcal serogroup B vaccine protection trial in Norway 1988-1991: trial surveillance by an independent group.1988 - 1991年挪威B群脑膜炎球菌疫苗保护试验：由独立小组进行的试验监测

NIPH Ann. 1991 Dec;14(2):135-6; discussion 136-7.

4

The Norwegian meningococcal group B outer membrane vesicle vaccine: side effects in phase II trials.挪威B群脑膜炎球菌外膜囊泡疫苗：II期试验中的副作用

NIPH Ann. 1991 Dec;14(2):95-101; discussion 101-2.

5

Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey.接种挪威B群脑膜炎球菌外膜囊泡疫苗后的杀菌抗体：简要调查

NIPH Ann. 1991 Dec;14(2):147-55; discussion 155-6.

6

Diagnostic work with suspected cases of systemic meningococcal disease in the Norwegian serogroup B vaccine protection trials.挪威B群脑膜炎球菌疫苗保护试验中疑似系统性脑膜炎球菌病病例的诊断工作。

NIPH Ann. 1991 Dec;14(2):103-6; discussion 121-3.

7

Design of clinical trials with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway.挪威针对B群脑膜炎球菌病全身性疾病的外膜囊泡疫苗的临床试验设计。

NIPH Ann. 1991 Dec;14(2):81-91; discussion 91-3.

8

Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba.抗B群脑膜炎奈瑟菌疫苗：古巴的保护试验和大规模疫苗接种结果

NIPH Ann. 1991 Dec;14(2):195-207; discussion 208-10.

9

Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease.B群脑膜炎球菌疫苗“Folkehelsa”的生产、特性及控制：一种针对B群脑膜炎球菌病的外膜囊泡疫苗

NIPH Ann. 1991 Dec;14(2):67-79; discussion 79-80.

10

Meningococcal serogroup B vaccine protection trial and follow-up studies in Chile. The Chilean National Committee for Meningococcal Disease.智利B群脑膜炎球菌疫苗保护试验及随访研究。智利国家脑膜炎球菌病委员会。

NIPH Ann. 1991 Dec;14(2):211-2; discussion 213.

引用本文的文献

1

Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults.健康成人鼻内接种蛋白酶体-福氏志贺菌2a脂多糖疫苗的安全性和免疫原性。

Infect Immun. 2001 Jul;69(7):4545-53. doi: 10.1128/IAI.69.7.4545-4553.2001.